Guide for collaboration with MAX IV
…collaborations targeting a Call for applications for funding, please follow the steps below: External collaborator discusses with the MAX IV contact person his/her intent of working on a joint project….
Search Results for: 청주출장 ☃ opgo90쩜컴 ♩ 부산안마 ❞ 안산안마 ⁂노원키스방 •창원오피 €동두천건마 target=_blank
Soft X-ray Laser
…a regular laser, leading to amplification. The light emitted by an FEL is coherent. The science The SXL will target the soft X-ray wavelength range 1-5 nm, and specialize in…
MAX IV research contributes to the development of new cancer drugs
…Therefore, you need to start at the protein level to fight cancer. Sprint Bioscience is working to develop new drug candidates by identifying small molecules (fragments) that can bind targeted…
Scientists unlock secrets of surface receptor activation opening door to engineer plant-microbe interactions
…well provide specific targets and an overall template for future engineering of plant receptors, according to the authors of the study report. BioMAX at MAX IV and DESY enabled the…
Programme
…Time: Talk: 8:30 “Exploring Correlated Atom Displacements in Protein Crystals through Femtosecond X-ray Snapshots and their Impact on Biomedical Sciences” – Gergely Katona, University of Gothenburg (SE) 8:50 “Developing fixed-target…
MicroMAX
…Fixed-target and HVE injector experiments is planned to ready for commissioning, and possibly other sample delivery methods. Both monochromators and CRL focusing will be available. The chopper and final one-micrometre…
User information
…with either the Eiger2 X CdTe 9M detector or the PSI Jungfrau 9M detector. Serial crystallography sample delivery that will be offered includes small fixed targets and injectors. NOTE: At…
Experimental station
…two detectors that can be easily exchanged. The diffractometer can be used for rotational crystallography but also for fixed-target serial crystallography. It will also be possible to use different injector…
Understanding NUDT15: lessen the efficacy of HCMV treatment
…are the most common clinical treatments for patients with such infections by targeting the viral DNA polymerase. The research done at BioMAX, led by Prof. Pål Stenmark from Stockholm University,…